Stoke Therapeutics Inc
NASDAQ:STOK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Stoke Therapeutics Inc
NASDAQ:STOK
|
US |
|
Toronto-Dominion Bank
TSX:TD
|
CA |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
B
|
Baidu Inc
BMV:BIDUN
|
CN |
|
K'S Holdings Corp
F:KSD
|
JP |
|
Airtasker Ltd
ASX:ART
|
AU |
|
S
|
Sahakol Equipment PCL
SET:SQ
|
TH |
|
A
|
American Water Works Company Inc
XMUN:AWC
|
US |
|
C
|
Coats Group PLC
F:4TC
|
UK |
|
Spectral Medical Inc
TSX:EDT
|
CA |
|
S
|
Sartorius AG
DUS:SRT
|
DE |
|
G
|
Glencore PLC
BMV:GLENN
|
CH |
|
T
|
TomCo Energy PLC
OTC:TMCGF
|
UK |
|
Unggul Indah Cahaya Tbk PT
IDX:UNIC
|
ID |
|
Shinpoong Pharmaceutical Co Ltd
KRX:019170
|
KR |
|
DSV A/S
CSE:DSV
|
DK |
|
E
|
Embotelladora Andina SA
SWB:AKOB
|
CL |
|
A
|
Agora Inc
XMUN:9AG1
|
US |
Bankruptcy Probability
Stoke Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Stoke Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Stoke Therapeutics Inc
NASDAQ:STOK
|
1.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Stoke Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Stoke Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.